Cite
APA Citation
Brenner, A., Cohen, Y., Vredenburgh, J., Peters, K., Nayak, L., Blumenthal, D., Bokstein, F., Breitbart, E., Bangio, L., Sher, N., Harats, D., & Wen, P. (n.d.). 2901 Phase 2 study of VB-, an anti-cancer gene therapy, as monotherapy followed by combination of VB-111 with bevacizumab, in patients with recurrent glioblastoma. European journal of cancer, 51, S584–. http://access.bl.uk/ark:/81055/vdc_100030628298.0x00003e